20 Participants NeededMy employer runs this trial

SUN-627 for Multiple Sclerosis

Recruiting at 2 trial locations
CG
Overseen ByChetan Gandhy, MD
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Sundance Biosciences, Inc.
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this Phase 2 clinical trial is to investigate the safety and tolerability of SUN-627 in men and women aged 18-70 years old with a diagnosis of non-active SPMS/PPMS.

Are You a Good Fit for This Trial?

This trial is for men and women aged 18-70 who have been diagnosed with non-active secondary progressive or primary progressive multiple sclerosis (SPMS/PPMS).

Inclusion Criteria

A level of disability that fits the study requirements
My multiple sclerosis has gotten worse over time.
I have primary progressive or non-active secondary progressive MS.
See 2 more

Exclusion Criteria

Current participation in another research study
Certain serious or unstable medical conditions that could make the study unsafe
I have used or need to use specific medications or treatments during the study.
See 2 more

What Are the Treatments Tested in This Trial?

Interventions

  • SUN-627

Trial Overview

The study is testing a new drug called SUN-627 compared to a placebo. Participants are randomly assigned to receive either the drug or an inactive substance, and researchers will monitor safety and how well people tolerate it.

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Placebo Group

Group I: SUN-627 Dose Level 2Experimental Treatment1 Intervention
Group II: SUN-627 Dose Level 1Experimental Treatment1 Intervention
Group III: SUN-627 PlaceboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Sundance Biosciences, Inc.

Lead Sponsor